Post-exertional malaise
| Post-exertional malaise | |
|---|---|
| Other names | Post-exertional symptom exacerbation (PESE) Postexertional malaise (PEM) Post-exertional neuroimmune exhaustion (PENE) |
| Chart of physical, cognitive, and emotional activities that may trigger PEM | |
| Symptoms | Worsening of symptoms after ordinary activity |
| Causes | Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Long COVID |
| Treatment | Symptomatic |
Post-exertional malaise (PEM), sometimes referred to as post-exertional symptom exacerbation (PESE)[1] or post-exertional neuroimmune exhaustion (PENE),[2] is a worsening of existing symptoms and/or appearance of new symptoms that occurs after minimal exertion.[3] It is the hallmark symptom of myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) and common in other infection-associated chronic conditions (IACCs) such as long COVID and fibromyalgia.[4][1] PEM is often severe enough to be disabling, and is triggered by ordinary activities that healthy people tolerate. Typically, it begins 12–48 hours after the activity that triggers it, and lasts for days, but this is highly variable and may persist much longer.[5][6][7] Management of PEM is symptom-based, and patients are recommended to pace their activities to avoid triggering PEM.
History and terminology
Melvin Ramsay, the infectious diseases specialist who coined the term "myalgic encephalomyelitis", insisted that:
Muscle fatigability whereby, even after a minor degree of physical effort, three, four or five days or longer elapse before full muscle power is restored is unique and constitutes the sheet anchor of diagnosis. Without it I would be unwilling to diagnose a patient as suffering from ME.[8]
Although Ramsay's focus on physical triggers of PEM is now understood to be too restrictive (see below), modern diagnostic criteria for ME/CFS all require PEM for diagnosis. This includes the Canadian Consensus Criteria from 2003[9], the International Consensus Criteria from 2011[3], and the Institute of Medicine criteria from 2015,[7] as well as later definitions.
The term "post-exertional malaise" itself was coined in a 1991 review summarizing the symptoms of ME/CFS.[10] However, the 2021 NICE committee stated they consider the term PEM outdated, as it may give the impression of just a "vague discomfort", and argued that the term post-exertional symptom exacerbation better captures the symptom. Nonetheless, they decided to continue using PEM as it is the more familiar term.[11]: 49
Description
Triggers
PEM is triggered by "minimal"[6] physical or mental activities that were previously tolerated, and that healthy people tolerate.[5] Which activities trigger PEM depends on illness severity.[12]
- For someone with so-called "mild" ME, PEM can be triggered by a full day of work.[12]
- For someone with so-called "moderate" ME, it can be triggered by attending a social event, grocery shopping, or cooking a full meal.[12]
- For someone with so-called "severe" ME, it can be triggered by taking a shower, or cooking a simple meal.[12]
- For someone with so-called "very severe" ME, it can be triggered by sitting up, saying a few words, or turning over in bed.[12]
In addition to these physical activity triggers, sensory overload,[13] emotional distress, injury, sleep deprivation, and infections are other potential triggers.[7] The resulting symptoms are disproportionate to the triggering activity and are often debilitating, potentially rendering someone who is able to leave the house at baseline housebound, or someone who is able to leave the bed at baseline bedbound.[3][7][14][5]
Timeline
Symptoms typically begin 12–48 hours after the triggering activity,[6] but may be immediate, or delayed up to 7 days.[7] PEM lasts "usually a day or longer",[3] but can span hours, days, weeks, or months.[7][15] In some cases, PEM can be permanent, and thus result in a permanent decrease of baseline capacity.[15][16]
Symptoms
Symptoms that may occur during PEM include cognitive impairment, flu-like symptoms, pain, weakness, dizziness, fatigue, and trouble sleeping.[7][5] In more severe cases, visual disturbances, stroke-like symptoms, and episodes of temporary paralysis have been recorded. Though typically cast as a worsening of existing symptoms, patients may experience some symptoms exclusively during PEM.[7] Patients often describe PEM as a "crash", "relapse", or "setback".[7]
The experience of PEM has been described as follows:
Some days can be absolutely horrendous […] when I wake up, it will feel like I'm being pushed into that like gravity is kind of wrapped it up and I'm being kind of sucked, pulled into the bed aches and pains. Because of my fine motor control, I struggle to do up buttons, zip up shirts […] hold a knife. Legs are heavy, it's almost like dragging feet across the floor, and every small […] effort and heart rate [spikes].[17]
“A few months ago, I went to a therapy pool which was heaven getting in, but once I got home I just about made it up the stairs and it was like a switch went off in my whole body and I face planted on the landing […] couldn't move anything in and my body felt like it shut down […] And I just had to lie there for half an hour […] I couldn't cope with anything. I couldn't speak. I couldn't look at anything. I was just faced down eyes shut for half an hour, and it is like a total sensory overload”[17]
When I do any activity that goes beyond what I can do—I literally collapse—my body is in major pain, it hurts to lay in bed, it hurts to think, I can’t hardly talk—I can't find the words, I feel my insides are at war.[18]
Variability
The level of activity that triggers PEM, as well as the symptoms, vary within individuals over time.[7] Due to this variability, affected people may be unable to predict what will trigger it.[5] This variable, relapsing-remitting pattern can cause one's abilities to fluctuate from one day to the next.[1]
Diagnosis
PEM is a hallmark symptom of ME/CFS and is common in long COVID.[19][20][21]
Its presence can be difficult to assess because patients and doctors may be unfamiliar with it.[1][20] Hence, the WHO recommends that clinicians explicitly ask long COVID patients whether symptoms worsen with activity.[1]
The 2-day Cardiopulmonary Exercise Test (CPET) may aid in documenting PEM, showing apparent abnormalities in the body's response to exercise.[22] The hand-grip test has also shown promise as a diagnostic tool.[23] Still, more research on developing a diagnostic test is needed.
Epidemiology
PEM is considered a cardinal symptom of ME/CFS by modern diagnostic criteria: the International Consensus Criteria,[5][3] the National Academy of Medicine criteria,[24][5] and NICE's definition of ME/CFS[14] all require it. The Canadian Consensus Criteria require "post exertional malaise and/or [post exertional] fatigue" instead.[25][26][27][24][18] On the other hand, the older Oxford Criteria lack any mention of PEM,[28] and the Fukuda Criteria consider it optional. Depending on the definition of ME/CFS used, PEM is present in 60 to 100% of ME/CFS patients.[7]
A majority of people with long COVID experience post-exertional malaise as well.[20]
Pathophysiology
Numerous biological findings have been associated with PEM.[29]
For example, extensive evidence from 2-day cardiopulmonary exercise testing (CPET) shows significant reductions in oxygen consumption and workload at the ventilatory anaerobic threshold during PEM.[30][31][32][33] As a result of these findings, PEM has been described as a state of "bioenergetic failure".[31]
Evidence also shows skeletal muscle tissue damage and intramuscular infiltration of immune cells in PEM.[34]
Management
There is no treatment or cure for PEM. Pacing, a management strategy in which someone plans their activities to stay within their limits, is essential to avoid triggering PEM.[35]
Graded exercise therapy is counter indicated in the presence of PEM,[36] and physical therapy for people with ME and long COVID must be modified to avoid triggering PEM in susceptible patients.[1]
References
- ^ a b c d e f Clinical management of COVID-19 Living Guideline. World Health Organization. January 13, 2023. pp. 113–4. Archived from the original on May 22, 2023. Retrieved January 14, 2023.
- ^ Twisk F (December 20, 2018). "Myalgic Encephalomyelitis or What? The International Consensus Criteria". Diagnostics. 9 (1): 1. doi:10.3390/diagnostics9010001. ISSN 2075-4418. PMC 6468846. PMID 30577429.
- ^ a b c d e Carruthers BM, van de Sande MI, De Meirleir KL, Klimas NG, Broderick G, Mitchell T, et al. (October 2011). "Myalgic encephalomyelitis: International Consensus Criteria". Journal of Internal Medicine. 270 (4): 327–338. doi:10.1111/j.1365-2796.2011.02428.x. PMC 3427890. PMID 21777306.
- ^ Barhorst EE, Boruch AE, Cook DB, Lindheimer JB (2022). "Pain-Related Post-Exertional Malaise in Myalgic Encephalomyelitis / Chronic Fatigue Syndrome (ME/CFS) and Fibromyalgia: A Systematic Review and Three-Level Meta-Analysis". Pain Medicine. 23 (6): 1144–1157. doi:10.1093/pm/pnab308. PMID 34668532. Archived from the original on May 21, 2023. Retrieved February 11, 2024.
- ^ a b c d e f g "Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS): Symptoms". Centers for Disease Control and Prevention. U.S. Department of Health & Human Services. July 14, 2017. Archived from the original on August 22, 2020. Retrieved September 23, 2017.
- ^ a b c "Terms: Post-exertional malaise". Myalgic encephalomyelitis (or encephalopathy)/chronic fatigue syndrome: diagnosis and management - Recommendations. NICE (Report). October 29, 2021. NICE guideline NG206. Archived from the original on December 29, 2021. Retrieved May 12, 2022.
- ^ a b c d e f g h i j k "Beyond Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Redefining an Illness" (PDF). National Academy of Medicine. 2015. pp. 78–86. Archived (PDF) from the original on January 20, 2017. Retrieved May 12, 2022.
- ^ Ramsay M (1988). Myalgic Encephalomyelitis and Postviral Fatigue States. Gower Medical Publishing.
- ^ Carruthers BM, Jain AK, De Meirleir KL, Peterson DL, Klimas NG, Lerner AM, et al. (January 2003). "Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Clinical Working Case Definition, Diagnostic and Treatment Protocols". Journal of Chronic Fatigue Syndrome. 11 (1): 7–115. doi:10.1300/J092v11n01_02. ISSN 1057-3321.
- ^ Komaroff AL, Buchwald D (January 1, 1991). "Symptoms and Signs of Chronic Fatigue Syndrome". Clinical Infectious Diseases. 13 (Supplement_1): S8–S11. doi:10.1093/clinids/13.Supplement_1.S8. ISSN 1537-6591.
- ^ National Guideline Centre (UK) (2021). Identifying and diagnosing ME/CFS: Myalgic encephalomyelitis (or encephalopathy) / chronic fatigue syndrome: diagnosis and management: Evidence review D (PDF). NICE Evidence Reviews Collection. London: National Institute for Health and Care Excellence (NICE). ISBN 978-1-4731-4221-3. PMID 35438857. Archived from the original on February 19, 2024. Retrieved September 23, 2023.
- ^ a b c d e Sommerfelt K, Schei T, Seton KA, Carding SR (June 14, 2024). "Assessing Functional Capacity in Myalgic Encephalopathy/Chronic Fatigue Syndrome: A Patient-Informed Questionnaire". Journal of Clinical Medicine. 13 (12): 3486. doi:10.3390/jcm13123486. ISSN 2077-0383. PMC 11204454. PMID 38930014.
- ^ Grach SL, Seltzer J, Chon TY, Ganesh R (October 2023). "Diagnosis and Management of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome". Mayo Clinic Proceedings. 98 (10): 1544–1551. doi:10.1016/j.mayocp.2023.07.032. PMID 37793728. S2CID 263665180.
- ^ a b "1.2 Suspecting ME/CFS". Myalgic encephalomyelitis (or encephalopathy)/chronic fatigue syndrome: diagnosis and management – Recommendations. NICE (Report). October 29, 2021. NICE guideline NG206. Archived from the original on December 29, 2021. Retrieved May 12, 2022.
- ^ a b "Recommendations | Myalgic encephalomyelitis (or encephalopathy)/chronic fatigue syndrome: diagnosis and management | Guidance | NICE". www.nice.org.uk. October 29, 2021.
- ^ Thoma M, Froehlich L, Hattesohl DB, Quante S, Jason LA, Scheibenbogen C (December 31, 2023). "Why the Psychosomatic View on Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Is Inconsistent with Current Evidence and Harmful to Patients". Medicina. 60 (1): 83. doi:10.3390/medicina60010083. ISSN 1648-9144. PMC 10819994. PMID 38256344.
- ^ a b Sas C, Lotankar Y, Adam R, Bradbury KJ, Cooper J, Hill DL, et al. (April 19, 2023). ""A Switch Went off in my Whole Body": Lived Experiences of Fatigue and Post-Exertional Malaise in Long Covid". Extended Abstracts of the 2023 CHI Conference on Human Factors in Computing Systems. CHI EA '23. New York, NY, USA: Association for Computing Machinery: 1–7. doi:10.1145/3544549.3585846. ISBN 978-1-4503-9422-2.
- ^ a b Wright Clayton E, Alegria M, Bateman L, Chu L, Cleeland C, Davis R, et al. (2015). "Beyond Myalgic Encephalomyelits/Chronic Fatigue Syndrome: Redefining an Illness (Report Guide for Clinicians)" (PDF). nationalacademies.org. Nancy Klimas, A. Martin Lerner, Cynthia Mulrow, Benjamin Natelson, Peter Rowe, Michael Shelanski. National Academy of Medicine (Institutes of Medicine). p. 7. Archived (PDF) from the original on September 29, 2018. Retrieved March 8, 2019.
- ^ "Information for Healthcare Providers | ME/CFS | CDC". www.cdc.gov. November 11, 2022. Archived from the original on August 9, 2020. Retrieved June 7, 2023.
- ^ a b c Davis HE, McCorkell L, Vogel JM, Topol EJ (January 13, 2023). "Long COVID: major findings, mechanisms and recommendations". Nature Reviews Microbiology. 21 (3): 133–146. doi:10.1038/s41579-022-00846-2. ISSN 1740-1534. PMC 9839201. PMID 36639608.
- ^ "Long COVID or Post-COVID Conditions". Centers for Disease Control and Prevention. September 1, 2022. Archived from the original on January 14, 2022. Retrieved July 3, 2022.
- ^ Eun-Jin L, Eun-Bum K, Eun-Su J, Chang-Gue S (2020). "The Prospects of the Two-Day Cardiopulmonary Exercise Test (CPET) in ME/CFS Patients: A Meta-Analysis". Journal of Clinical Medicine. 9 (12). J Clin Med.: 4040. doi:10.3390/jcm9124040. PMC 7765094. PMID 33327624.
- ^ Paffrath A, Kim L, Kedor C, Stein E, Rust R, Freitag H, et al. (April 8, 2024). "Impaired Hand Grip Strength Correlates with Greater Disability and Symptom Severity in Post-COVID Myalgic Encephalomyelitis/Chronic Fatigue Syndrome". Journal of Clinical Medicine. 13 (7): 2153. doi:10.3390/jcm13072153. ISSN 2077-0383. PMC 11012649. PMID 38610918.
- ^ a b "IOM 2015 Diagnostic Criteria | Diagnosis | Healthcare Providers | Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) | CDC". www.cdc.gov. November 8, 2018. Archived from the original on March 8, 2019. Retrieved March 8, 2019.
- ^ Myhill S, Booth NE, McLaren-Howard J (2009). "Chronic fatigue syndrome and mitochondrial dysfunction" (PDF). Int J Clin Exp Med. 2 (1): 1–16. PMC 2680051. PMID 19436827. Archived (PDF) from the original on July 11, 2019. Retrieved March 8, 2019.
- ^ Carruthers BM, van de Sande MI (2005). "Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: A Clinical Case Definition and Guidelines for Medical Practitioners" (PDF). sacfs.asn.au. p. 8. Archived (PDF) from the original on March 4, 2019. Retrieved March 8, 2019.
There is an inappropriate loss of physical and mental stamina, rapid muscular and cognitive fatigability, post exertional malaise and/or fatigue and/or pain and a tendency for other associated symptoms within the patient's cluster of symptoms to worsen.
- ^ "Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) Key Facts" (PDF). nap.edu. 2015. p. 2. Archived (PDF) from the original on March 27, 2019. Retrieved March 8, 2019.
- ^ Sharpe M (February 1991). "A report--chronic fatigue syndrome: guidelines for research". Journal of the Royal Society of Medicine. 84 (2): 118–121. doi:10.1177/014107689108400224. PMC 1293107. PMID 1999813.
- ^ Haunhorst S, Dudziak D, Scheibenbogen C, Seifert M, Sotzny F, Finke C, et al. (February 1, 2025). "Towards an understanding of physical activity-induced post-exertional malaise: Insights into microvascular alterations and immunometabolic interactions in post-COVID condition and myalgic encephalomyelitis/chronic fatigue syndrome". Infection. 53 (1): 1–13. doi:10.1007/s15010-024-02386-8. ISSN 1439-0973. PMC 11825644. PMID 39240417.
- ^ Keller B, Receno CN, Franconi CJ, Harenberg S, Stevens J, Mao X, et al. (July 5, 2024). "Cardiopulmonary and metabolic responses during a 2-day CPET in myalgic encephalomyelitis/chronic fatigue syndrome: translating reduced oxygen consumption to impairment status to treatment considerations". Journal of Translational Medicine. 22 (1). doi:10.1186/s12967-024-05410-5. ISSN 1479-5876. PMC 11229500. PMID 38965566.
- ^ a b Davenport T, Stevens S, Stevens J, Ness MV (January 22, 2026), ME/CFS and Long COVID Demonstrate Similar Bioenergetic Impairment and Recovery Failure on Two-Day Cardiopulmonary Exercise Testing, doi:10.21203/rs.3.rs-8606329/v1, retrieved March 6, 2026
- ^ Lim EJ, Kang EB, Jang ES, Son CG (December 14, 2020). "The Prospects of the Two-Day Cardiopulmonary Exercise Test (CPET) in ME/CFS Patients: A Meta-Analysis". Journal of Clinical Medicine. 9 (12): 4040. doi:10.3390/jcm9124040. ISSN 2077-0383. PMC 7765094.
- ^ Franklin JD, Graham M (July 3, 2022). "Repeated maximal exercise tests of peak oxygen consumption in people with myalgic encephalomyelitis/chronic fatigue syndrome: a systematic review and meta-analysis". Fatigue: Biomedicine, Health & Behavior. 10 (3): 119–135. doi:10.1080/21641846.2022.2108628. ISSN 2164-1846.
- ^ Charlton BT, Goulding RP, Jaspers RT, Appelman B, van Vugt M, Wüst RC (2025-07). "Skeletal muscle adaptations and post-exertional malaise in long COVID". Trends in Endocrinology & Metabolism. 36 (7): 614–622. doi:10.1016/j.tem.2024.11.008. hdl:1871.1/0d8669d2-74dd-4f50-b1ff-e845c91dc7eb.
{{cite journal}}: Check date values in:|date=(help) - ^ "1.11 Managing ME/CFS". Myalgic encephalomyelitis (or encephalopathy)/chronic fatigue syndrome: diagnosis and management – Recommendations. NICE (Report). October 29, 2021. NICE guideline NG206. Archived from the original on December 29, 2021. Retrieved July 17, 2022.
- ^ van Rhijn-Brouwer FC, Hellemons M, Stingl M, Hoffmann K, VanDerNagel J, Davenport TE, et al. (2024-06). "Graded exercise therapy should not be recommended for patients with post-exertional malaise". Nature Reviews Cardiology. 21 (6): 430–431. doi:10.1038/s41569-024-00992-5. ISSN 1759-5010.
{{cite journal}}: Check date values in:|date=(help)